Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States

References

• Deeks SG, Archin N, Cannon P, et al. Research priorities for an HIV cure: International AIDS society global scientific strategy 2021. Nat Med. 2021;27(12):2085–2098.
   PubMed Web of Science ®Google Scholar
• TAG. Research toward a cure trials; 2023. Available from: http://www.treatmentactiongroup.org/cure/trials
   Google Scholar
• Dresser R. First-in-human HIV-remission studies: reducing and justifying risk. J Med Ethics. 2017;43(2):78–81.
   PubMed Web of Science ®Google Scholar
• Dubé K, Henderson GE, Margolis DM. Framing expectations in early HIV cure research. Trends Microbiol. 2014;22(10):547–549.
   PubMed Web of Science ®Google Scholar
• Julg B, Dee L, Ananworanich J, et al. Recommendations for analytical treatment interruptions in HIV research trials. Report of a consensus meeting. Lancet HIV. 2019;6(4):e259–e268.
   PubMed Web of Science ®Google Scholar
• Neergaard R, Jones NL, Roebuck C, et al. “I know that I was a part of making a difference”: participant motivations for joining a cure-directed HIV trial with an analytical treatment interruption. AIDS Res Hum Retroviruses. 2023;39(8):414–421.
   PubMed Web of Science ®Google Scholar
• The Denver principles. In: ACT Up Historical Archive [Internet]; 1983 [cited 2021 Oct 4]. Available from: https://actupny.org/documents/Denver.html
   Google Scholar
• AIDS United. Meaningful involvement of people with HIV/AIDS (MIPA); 2021 [cited 2021 Oct 5]. Available from: https://www.aidsunited.org/resources/meaningful-involvement-of-people-with-hivaids-mipa
   Google Scholar
• Lau J, Smith M, Allan B, et al. Time for revolution? Enhancing meaningful involvement of people living with HIV in HIV cure-focused science. J Virus Erad. 2020;6(4):100018.
   PubMed Web of Science ®Google Scholar
• Karris MY, Dubé K, Moore AA. What lessons it might teach Us? Community engagement in HIV research. Curr Opin HIV AIDS. 2020;15(2):142–149.
   PubMed Web of Science ®Google Scholar
• Henderson GE, Waltz M, Meagher K, et al. Going off antiretroviral treatment in a closely monitored HIV “cure” trial: longitudinal assessments of acutely diagnosed trial participants and decliners. J Int AIDS Soc. 2019;22(3):e25260.
   PubMed Web of Science ®Google Scholar
• Henderson GE, Peay HL, Kroon E, et al. Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment. J Med Ethics. 2018;44(4):270–276.
   PubMed Web of Science ®Google Scholar
• Dubé K, Evans D, Dee L, et al. “We need to deploy them very thoughtfully and carefully”: perceptions of analytical treatment interruptions in HIV cure. AIDS Res Hum Retroviruses. 2018;34(1):67–79.
   PubMed Web of Science ®Google Scholar
• Garner SA, Rennie S, Ananworanich J, et al. Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations. J Virus Erad. 2017;3(2):82–84.
   PubMed Web of Science ®Google Scholar
• Eyal N, Holtzman LG, Deeks SG. Ethical issues in HIV remission trials. Curr Opin HIV AIDS. 2018;13(5):422–427.
   PubMed Web of Science ®Google Scholar
• Diepstra KL, Barr L, Palm D, et al. Participant perspectives and experiences entering an intensively monitored antiretroviral pause: results from the AIDS clinical trials group A5345 biomarker study. AIDS Res Hum Retroviruses. 2021;37(6):489–501.
   PubMed Web of Science ®Google Scholar
• Dubé K, Eskaf S, Barr L, et al. Participant perspectives and experiences following an intensively monitored antiretroviral pause in the United States: Results from the AIDS clinical trials group A5345 biomarker study. AIDS Res Hum Retroviruses. 2022;38(6):510–517.
   PubMed Web of Science ®Google Scholar
• Arnold M, Evans D, Vergel N. Recruitment and ethical considerations in HIV cure trials requiring treatment interruption. J Virus Erad. 2015;1(1):43–48.
   PubMedGoogle Scholar
• Lo B, Grady C, Working Group on Ethics of the International AIDS Society. Ethical considerations in HIV cure research: points to consider. Curr Opin HIV AIDS. 2013;8(3):243–249.
   PubMed Web of Science ®Google Scholar
• Dubé K, Kanazawa J, Taylor J, et al. Ethics of HIV cure research: an unfinished agenda. BMC Med Ethics. 2021;22(1):83.
   PubMed Web of Science ®Google Scholar
• Peluso MJ, Dee L, Campbell D, et al. A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption. J Virus Erad. 2020;6(1):34–37.
   PubMed Web of Science ®Google Scholar
• Dubé K, Kanazawa JT, Dee L, et al. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research. HIV Res Clin Pract. 2021;22(1):14–30.
   PubMed Web of Science ®Google Scholar
• Dawson L. Human immunodeficiency virus transmission risk in analytical treatment interruption studies: relational factors and moral responsibility. J Infect Dis. 2019;220(Suppl 1):S12–S15.
   PubMedGoogle Scholar
• Eyal N. How to address the risk of HIV transmission in remission studies with treatment interruption: the low-hanging fruit approach. J Infect Dis. 2019;220(Suppl 1):S7–S11.
   PubMedGoogle Scholar
• Dubé K, Peterson B, Jones NL, et al. Community engagement group model in basic and biomedical research: Lessons learned from the BEAT-HIV Delaney Collaboratory towards an HIV-1 cure. Res Involv Engagem. 2023;9(1):39.
   PubMedGoogle Scholar
• Wallterstein N, Duran B, Oetzel J, et al. Community-based participatory research for health: advancing social and health equity. San Francisco (CA): Jossey-Bas; 2017.
   Google Scholar
• Seifer SD, Michaels M, Collins S. Applying community-based participatory research principles and approaches in clinical trials: forging a new model for cancer clinical research. Prog Community Health Partnersh. 2010;4:37–46.
   PubMedGoogle Scholar
• Cresswell J. Research design. Qualitative, quantitative, and mixed methods approaches. 4th ed. Thousand Oaks, CA: Sage Publications; 2013.
   Google Scholar
• Cresswell J. Turning the story. Qualitative inquiry and research design. Thousand Oaks, CA: Sage Publications, Inc; 1998. p. 219–229.
   Google Scholar
• Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–1288.
   PubMed Web of Science ®Google Scholar
• Grossman CI, Ross AL, Auerbach JD, et al. Towards multidisciplinary HIV-cure research: Integrating social science with biomedical research. Trends Microbiol. 2016;24(1):5–11.
   PubMed Web of Science ®Google Scholar
• Dubé K, Auerbach JD, Stirratt MJ, et al. Applying the behavioural and social sciences research (BSSR) functional framework to HIV cure research. J Int AIDS Soc. 2019;22:e25404.
   PubMed Web of Science ®Google Scholar
• Barr L, Jefferys R. A landscape analysis of HIV cure-related clinical trials and observational studies in 2018. J Virus Erad. 2019;5(4):212–219.
   PubMed Web of Science ®Google Scholar
• Barr L, Jefferys R. A landscape analysis of HIV cure-related clinical research in 2019. J Virus Erad. 2020;6(4):100010.
   PubMed Web of Science ®Google Scholar
• Johnston R, Heitzeg M. Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review. AIDS Res Hum Retroviruses. 2015;31(1):85–97.
   PubMed Web of Science ®Google Scholar
• Roberts C, Creamer E, Boone CA, et al. Short communication: Population representative in HIV cure research: a review of diversity within HIV cure studies based in the United States. AIDS Res Hum Retroviruses. 2022;38(8):631–644.
   PubMed Web of Science ®Google Scholar
• De Scheerder M, Bilsen WV, Dullaers M, et al. Motivations, barriers and experiences of participants in an HIV reservoir trial. J Virus Erad. 2021;7(1):100029.
   PubMed Web of Science ®Google Scholar
• Dubé K, Hosey L, Starr K, et al. Participant perspectives in an HIV cure-related trial conducted exclusively in women in the United States: results from AIDS clinical trials group (ACTG) 5366. AIDS Res Hum Retroviruses. 2020;36(4):268–282.
   PubMed Web of Science ®Google Scholar
• Dubé K, Taylor J, Sylla L, et al. ‘Well, it’s the risk of the unknown … right ?’: a qualitative study of perceived risks and benefits of HIV cure research in the United States. PLOS One. 2017;12(1):e0170112.
   PubMed Web of Science ®Google Scholar
• Horng S, Grady C. Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism. IRB. 2003;25(1):11–16.
   PubMedGoogle Scholar
• Henderson GE. The ethics of HIV ‘cure’ research: what can we learn from consent forms? AIDS Res Hum Retroviruses. 2015;31(1):56–63.
   PubMed Web of Science ®Google Scholar
• Simpkin AL, Armstrong KA. Communicating uncertainty: a narrative review and framework for future research. J Gen Intern Med. 2019;34(11):2586–2591.
   PubMed Web of Science ®Google Scholar
• Hare C. Risk and radical uncertainty in HIV research. J Med Ethics. 2017;43(2):87–89.
   PubMed Web of Science ®Google Scholar
• Lantos J. The “inclusion benefit” in clinical trials. J Pediatr. 1999;134(2):130–131.
   PubMed Web of Science ®Google Scholar
• Rennie S, Day S, Mathews A, et al. The role of inclusion benefits in ethics committee assessment of research studies. Ethics Hum Res. 2019;41(3):13–22.
   PubMedGoogle Scholar
• Gilbertson A, Kelly EP, Rennie S, et al. Indirect benefits in HIV cure clinical research: a qualitative analysis. AIDS Res Hum Retroviruses. 2019;35(1):100–107.
   PubMed Web of Science ®Google Scholar
• Gelinas L, Largent EA, Cohen IG, et al. A framework for ethical payment to research participants. N Engl J Med. 2018;378(8):766–771.
   PubMed Web of Science ®Google Scholar
• Peluso MJ, Dee L, Shao S, et al. Operationalizing HIV cure-related trials with analytic treatment interruptions during the SARS-Cov-2 pandemic: a collaborative approach. Clin Infect Dis. 2021;72(10):1843–1849.
   PubMed Web of Science ®Google Scholar
• Guest G, Bunce A, Johnson L. How many interviews are enough?: an experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.
   Web of Science ®Google Scholar